Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization of adverse cutaneous effects in the setting of enfortumab vedotin for metastatic urothelial carcinoma: A retrospective review.

Autor: Malik R; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Xiang DH; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Riew GJ; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Sanchez-Melendez S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Ponce Health Sciences University, School of Medicine, Ponce, Puerto Rico., Afvari S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; New York Medical College, Valhalla, New York., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Nambudiri VE; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address: vnambudiri@bwh.harvard.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Oct; Vol. 91 (4), pp. 753-755. Date of Electronic Publication: 2024 Jun 21.

Exhalation.

Autor: Xiang DH; Harvard Medical School, Boston, MA, USA.

Publikováno v: Palliative & supportive care [Palliat Support Care] 2024 Sep 16, pp. 1. Date of Electronic Publication: 2024 Sep 16.